Innovate in India for Inclusiveness

closed

The development objective of Innovate in India for Inclusiveness is to facilitate innovation in biopharmaceutical products and medical devices that address public health priorities in India. This project has three components. 1) The first component, Strengthening the pilot-to-market innovation ecosystem, aims to provide grant funding to support the creation of centers of excellence for validation, early stage bio-manufacturing, clinical development, training, and technology transfer. It has the following five subcomponents: (i) Shared facilities; (ii) Scientific research; (iii) Clinical trial network; (iv) Training; and (v) Technology transfer. 2) The second component, Accelerating the pilot-to-market process for specific products, aims to provide grant funding to consortia of private, public, and academic institutions, led by cutting-edge institutions in their respective field, to accelerate the development of low-cost, select vaccines, biopharmaceuticals, diagnostics, and medical devices that address public health priorities in India. It has the following three subcomponents: (i) Vaccines; (ii) Biosimilars; and (iii) Medical devices (instruments and diagnostics). 3) The third component, Project management and monitoring and evaluation, aims to cover the operating costs incurred by Biotechnology Industry Research Assistance Council (BIRAC) in the implementation of the project.